Neftaly Allergy Immunotherapy Protocols

Introduction

Allergy Immunotherapy (AIT), also known as desensitization or hypo-sensitization, is a highly effective, disease-modifying treatment for patients with allergic conditions. At Neftaly, our immunotherapy protocols are designed to reduce allergic symptoms, improve quality of life, and prevent the progression of allergic diseases—especially in patients who do not respond adequately to pharmacotherapy or environmental controls.

---

Objectives of Neftaly Allergy Immunotherapy Protocols

• To provide safe and standardized immunotherapy to eligible patients.
• To decrease sensitivity to specific allergens over time.
• To reduce the need for long-term allergy medications.
• To improve patient outcomes with evidence-based and personalized care.

---

1. Indications for Allergy Immunotherapy

AIT is recommended for:

• Allergic rhinitis (seasonal or perennial)
• Allergic conjunctivitis
• Allergic asthma (mild to moderate, allergic subtype)
• Insect venom allergy (bee, wasp, hornet stings)
• Selected cases of atopic dermatitis (if aeroallergens are significant triggers)

⚠️ Note: AIT is not typically recommended for food allergies, except under specialized clinical protocols.

---

2. Types of Immunotherapy

Type	Description	Route
SCIT (Subcutaneous Immunotherapy)	Traditional “allergy shots” using allergen extracts	Injected under the skin
SLIT (Sublingual Immunotherapy)	Allergen tablets or drops placed under the tongue	Oral (sublingual)

---

3. Pre-Treatment Assessment

Before starting AIT, Neftaly protocols require:

a. Clinical Evaluation

• Detailed allergy history
• Impact on daily life
• Previous treatments and response

b. Allergy Testing

• Skin prick testing (SPT)
• Specific IgE blood tests
• Identification of relevant allergens (e.g., pollen, dust mites, molds, pet dander, insect venom)

c. Medical Suitability

• Asthma control assessment (spirometry if needed)
• Cardiovascular evaluation
• Medication review (e.g., beta-blockers may interfere with epinephrine use)
• Informed consent and patient education

---

4. Neftaly Immunotherapy Protocols

A. Subcutaneous Immunotherapy (SCIT)

Phase 1: Build-Up Phase

• Frequency: 1–2 times per week
• Duration: 3–6 months
• Goal: Gradually increase allergen dose to target maintenance level

Phase 2: Maintenance Phase

• Frequency: Every 2–4 weeks
• Duration: Typically 3–5 years
• Goal: Maintain tolerance and symptom relief

Administration & Monitoring

• Administered in a clinical setting
• 30-minute post-injection observation for adverse reactions
• Emergency protocols in place (e.g., epinephrine, antihistamines)

---

B. Sublingual Immunotherapy (SLIT)

• Form: Allergen tablets or drops (e.g., grass pollen, dust mite)
• Administration: First dose under medical supervision, then daily at home
• Duration: Minimum of 3 years
• Advantages: Needle-free, better adherence for some patients

---

5. Contraindications and Precautions

Absolute Contraindications:

• Severe, uncontrolled asthma
• Severe immunodeficiency or autoimmune disease
• Malignancies
• History of severe systemic reactions to immunotherapy

Relative Contraindications:

• Pregnancy (do not start new AIT; may continue if already on maintenance)
• Use of beta-blockers or ACE inhibitors (increased risk during anaphylaxis)
• Poor adherence to follow-up and treatment plans

---

6. Adverse Effects and Emergency Management

Reaction Type	Symptoms	Management
Local Reactions	Redness, swelling at injection site	Cold compress, antihistamines if needed
Systemic Reactions	Sneezing, hives, asthma, abdominal symptoms	Antihistamines, monitor closely
Anaphylaxis (rare)	Difficulty breathing, hypotension, dizziness	Immediate epinephrine, emergency response

---

7. Monitoring and Follow-Up

• Regular symptom tracking and medication use
• Annual re-evaluation of allergy status
• Adjustment of allergen doses if needed
• Education on emergency response and adherence

---

8. Patient Education and Empowerment

Neftaly emphasizes:

• Informed consent before starting AIT
• Training in epinephrine auto-injector use
• Understanding the long-term benefits and commitment
• Recognizing early signs of allergic reactions

---

9. Integration into Primary Care and Community Programs

Neftaly supports:

• Training for general practitioners and nurses
• School-based allergy support programs
• Remote or community-based SLIT monitoring
• Digital tools for adherence tracking and reminders

---

Conclusion

Allergy Immunotherapy is a safe, effective, and transformative option for individuals suffering from moderate to severe allergic conditions. Neftaly’s Allergy Immunotherapy Protocols ensure the highest standards of care through comprehensive assessment, personalized treatment plans, and continuous monitoring—empowering patients to live free from the burdens of chronic allergic disease.